Widely despised pharmaceutical CEO Martin Shkreli arrested for alleged securities fraud
Martin Shkreli, the 32-year-old chief executive of Turing Pharmaceuticals who gained infamy for jacking up the price of a life-saving drug to $750 a dose, from $13.50, has been arrested on suspicion that he illegally siphoned shares from a biotech firm he founded to pay for unrelated debts, Bloomberg reported Thursday morning. Update: Reuters confirmed that FBI agents arrested Shkreli early Thursday; he was wearing a hoodie as he was escorted from his Midtown Manhattan apartment tower.
Shkreli was ousted from the earlier firm he started, Retrophin Inc., in 2014, and the board of that company has sued him, accusing him of misappropriating money from Retrophin to pay off investors in his defunct hedge fund, MSMB Capital Management. The Securities and Exchange Commission is expected to file a civil suit against Shkreli that hews closely to the federal criminal case.
After becoming a poster boy for greed and pharmaceutical excess with his 5,000 percent price hike for Daraprim, Shkreli purchased a majority stake in KaloBios Pharmaceuticals Inc., and KaloBios quickly and sharply raised the price of a medicine to fight Chagas, a fatal parasitic infection common in Latin America. And Shkreli, who first made a fortune shorting biopharmaceutical stocks, seems to be comfortable with his villain status. At a Forbes summit in New York earlier in December, the young chief executive, wearing a hoodie, said that if he were given a do-over on Daraprim pricing, "I probably would have raised the price higher" because "my investors expect me to maximize profits."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Ukraine fires ATACMS, Russia ups hybrid war
Speed Read Ukraine shot U.S.-provided long-range missiles and Russia threatened retaliation
By Peter Weber, The Week US Published
-
New York DA floats 4-year Trump sentencing freeze
Speed Read President-elect Donald Trump's sentencing is on hold, and his lawyers are pushing to dismiss the case while he's in office
By Rafi Schwartz, The Week US Published
-
Wicked fails to defy gravity
Talking Point Film version of hit stage musical weighed down by 'sense of self-importance'
By Tess Foley-Cox Published
-
Boeing machinists approve contract, end strike
Speed Read The company's largest union approved the new contract offer, ending a seven-week strike
By Peter Weber, The Week US Published
-
US economy still strong in final preelection report
Speed Read It grew at a solid 2.8% annual rate from July through September
By Peter Weber, The Week US Published
-
Boeing machinists reject deal, continue strike
Speed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
By Peter Weber, The Week US Published
-
Ports reopen after dockworkers halt strike
Speed Read The 36 ports that closed this week, from Maine to Texas, will start reopening today
By Peter Weber, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published